Qingdao Baheal Medical INC. (SHE:301015)
China · Delayed Price · Currency is CNY 23.27
-0.86 (-3.56%)
Sep 11, 2026, 11:25 AM CST
SHE:301015 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 7,315 | 7,507 | 8,094 | 8,256 | 7,510 | 7,052 |
Revenue Growth | -6.87% | -7.26% | -1.96% | 9.94% | 6.50% | 19.94% |
Gross Profit Gross Profit Growth | 2,816 | 2,766 | 2,866 | 2,751 | 2,084 | 1,774 |
Operating Income Operating Income Growth | 744.19 | 723.41 | 981.91 | 1,053 | 712.6 | 614.75 |
Net Income Net Income Growth | 536.22 | 474.69 | 691.59 | 712.06 | 502.09 | 421.64 |
Earnings Per Share EPS Growth | 1.00 | 0.89 | 1.28 | 1.33 | 0.96 | 0.85 |
EPS Growth | 17.21% | -30.47% | -3.76% | 38.54% | 12.94% | 46.55% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Brand Operation Business Segment Brand Operation Business Segment Growth | 5,624 | 5,559 | 5,092 | 3,700 | 2,905 |
Pharmaceutical Wholesale and Distribution Business Division Pharmaceutical Wholesale and Distribution Business Division Growth | 1,458 | 2,136 | 2,774 | 3,434 | 3,706 |
Retail Business Segment Retail Business Segment Growth | 397.66 | 373.3 | 360.02 | 359.71 | 418.6 |
Unallocated Other Operating Income Unallocated Other Operating Income Growth | 26.67 | 26.03 | 29.96 | 15.19 | 22 |
Total Total Growth | 7,507 | 8,094 | 8,256 | 7,510 | 7,052 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 2,169 | 2,402 | 1,512 | 1,372 | 1,075 | 1,317 |
Total Debt Total Debt Growth | 3,823 | 3,380 | 2,385 | 1,455 | 1,338 | 1,226 |
Net Cash (Debt) Net Cash Growth | -1,654 | -978.05 | -872.59 | -82.51 | -262.71 | 90.77 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.08 | -1.83 | -1.61 | -0.15 | -0.50 | 0.18 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 580.7 | 934.45 | 813.85 | 799.5 | 305.75 | 181.3 |
Capital Expenditures CapEx Growth | -285.2 | -288.93 | -303.99 | -185.49 | -105.32 | -27.49 |
Free Cash Flow Free Cash Flow Growth | 295.5 | 645.52 | 509.86 | 614.01 | 200.43 | 153.81 |
Free Cash Flow Growth | -32.48% | 26.61% | -16.96% | 206.34% | 30.31% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Gross Margin | 38.49% | 36.84% | 35.41% | 33.32% | 27.75% | 25.16% |
Operating Margin | 10.17% | 9.64% | 12.13% | 12.75% | 9.49% | 8.72% |
Pretax Margin | 10.95% | 9.63% | 11.94% | 12.45% | 8.90% | 8.02% |
Profit Margin | 7.33% | 6.32% | 8.54% | 8.63% | 6.69% | 5.98% |
FCF Margin | 4.04% | 8.60% | 6.30% | 7.44% | 2.67% | 2.18% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.571 | 0.571 | 0.762 | - | 0.762 | 0.667 |
Dividend Per Share Growth | -25.07% | -25.07% | - | - | 14.24% | - |
Dividend Yield | 2.48% | 2.48% | 3.37% | - | 3.60% | 2.56% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | 24.20 | 26.13 | 18.40 | 26.44 | 24.93 | 37.74 |
Forward PE | 22.14 | 16.50 | 13.27 | 25.05 | 21.53 | 33.48 |
P/FCF Ratio | 42.92 | 19.22 | 24.96 | 30.67 | 62.46 | 103.45 |
PS Ratio | 1.73 | 1.65 | 1.57 | 2.28 | 1.67 | 2.26 |